• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, December 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Carl F. Ware receives ICIS Honorary Lifetime Membership Award

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

LA JOLLA, CALIF. – June 29, 2021 – Carl F. Ware, Ph.D., director of the Inflammatory Diseases Center at Sanford Burhnam Prebys, has received the 2021 International Cytokine & Interferon Society Honorary Lifetime Membership Award. The award is a tribute to his seminal and original contributions to our understanding of the role of cytokines in immunology and active engagement in cytokine research.

“It’s a tremendous honor to receive this prestigious award,” says Ware. “I’m grateful for the many outstanding scientists and students I’ve worked with over the years who have contributed to the field of cytokines. It’s especially gratifying to see how our discoveries are now being translated into much-needed therapies for infectious and inflammatory diseases–and even cancer.”

Ware began studying cytokines as a graduate student in the early 1970s. His decades-long career has produced many scientific breakthroughs, including the discoveries of several cytokines controlling immune defenses to viral infections. Recently, Ware showed that LIGHT levels are increased in COVID-19 patients progressing to pneumonia, which launched a Phase 2 trial using a LIGHT antibody that he developed.

With continuous support from the National Institutes of Health, Ware continues to investigate cytokine networks as a source of therapeutics for diseases without effective treatment. His work is providing new insights into immune evasion mechanisms and novel approaches to treat persistent viral infections. He is the holder of 18 patents, including one recently licensed to develop a new drug for patients with autoimmune diseases.

Among his several positions, he served with distinction as president of the International Cytokine Society and is on the scientific advisory board of the International Congress on TNF-related cytokines for many years. He has served on numerous advisory boards and study sections including the editorial board of the Journal of Interferon and Cytokine Research from 1996 to the present. In addition to his many scientific achievements, Ware has an outstanding record of mentorship with trainees who continue to shape the cytokine field all over the world.

###

About Sanford Burnham Prebys Medical Research Institute

Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Media Contact
Susan Gammon
[email protected]

Tags: BiologyBiotechnologyCell BiologyImmunology/Allergies/Asthma
Share12Tweet8Share2ShareShareShare2

Related Posts

Male-Biased Immune Changes in Late-Onset Preeclampsia

Male-Biased Immune Changes in Late-Onset Preeclampsia

December 24, 2025
blank

Mitochondrial Recombination Fuels Rapid Fish DNA Evolution

December 24, 2025

Immune Response Differences Influence Parkinson’s Disease Progression

December 24, 2025

Unlocking Xiangyang Black Pig Genetics Through Resequencing

December 24, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    54 shares
    Share 22 Tweet 14
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Muscle Health Transitions and Risks in Seniors

Exosomes: Aging Insights, Therapeutic Potential, and Challenges

miR-155 Inhibits Angiotensin Receptor in Placental Development

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.